Genetic tests are not widely available and still remain expensive, and IHC has a high percentage of variability, especially in reporting hormonal status (ER and PR), thus more and more studies are focusing on the role of imaging in predicting breast cancer molecular status. This evidence concerns the gene PGR and breast cancer.